Infertility Clinical Trial
Official title:
Cervical Surgery and the Fertility Effect
Over the last 20 years, cervical screening programs have had huge success in reducing
cervical cancer rates. These programs have done this by screening women at risk of
developing cancer with regular smear tests. Women with abnormal smears are followed up in
colposcopy clinics, and where needed, cervical surgery is performed to remove pre-cancerous
areas on the cervix.
Surgery to the cervix can include LLETZ (Large loop excision of the transformation zone)
treatment or cone biopsy. Many studies in the last few years have looked at the impact that
this necessary surgery can have on the function of the cervix. These studies have mainly
found an association between LLETZ treatment and an increased risk of preterm labour. There
have been no large studies investigating the effect cervical surgery may have on fertility.
The investigators would like to examine the impact that cervical surgery may have on a
woman's future fertility. It has been postulated that cervical surgery may cause the cervix
to close, preventing sperm getting through or that it may cause changes in the secretions of
the cervix, secretions that are necessary for normal interaction with sperm.
The investigators would like to send a questionnaire to women who have attended colposcopy.
The investigators will ask these women a series of questions relating to fertility desires
and divide the women in to two groups depending on whether the women needed cervical surgery
for pre-cancerous lesions or not.
Hypothesis: That cervical surgery has an impact on the function of the cervix and on
fertility.
With an increasing amount of young women undergoing cervical surgery for the treatment of
CIN, the fertility consequences need to be investigated. Infertility is estimated to affect
approximately one in six to one in ten couples and only about half of these seek medical
assistance. Causes of infertility include anovulation, tubal occlusion, endometriosis,
cervical and male factor. In approximately one third of cases, there is no cause found as to
why a couple are unable to conceive.
Many recent studies have looked at the likely association between cervical surgery and
increased risk of preterm labour. It has also been suggested in an Australian study that
even women with untreated CIN have a higher risk for preterm delivery, although it is
unclear whether this is related to the CIN itself, HPV effect or inflammatory changes in the
cervix. Studies are needed to clarify this further.
There are few studies published in the literature, investigating the possibility that
cervical surgery has an effect on long term fertility. Most of these studies are small and
under-powered.
Kennedy et al in 1993 raised the possibility of cervical stenosis and amucorrhoea following
LLETZ in their retrospective study. In this study, 15 out of 2315 women who had LLETZ, were
subsequently seen in a fertility clinic. 2 out of these 15 women studied had cervical
stenosis. The authors advised caution with the use of LLETZ in young women with mild to
moderate dyskaryosis, although the investigators did concede that their numbers were small
to draw definite conclusions.
Bigrigg et al in 1994 performed a case controlled questionnaire regarding the safety and
efficacy of LLETZ and this involved questions regarding infertility. There were 250 matched
pairs- women who had had a LLETZ (study group) and those women identified who had normal
cytology from their database (control group), for the entire study, but only 134 women
answered the questions on infertility (72 in the LLETZ group and 62 in the control group).
The investigators reported no apparent difference in infertility between the groups. Again
this study was limited by size -72 in the study group and 62 in the control group could
remember how long it took to conceive.
Cruickshank et al in 1995, followed up 653 women following LLETZ with a questionnaire and
found that none of the women subsequently investigated for infertility were found to have
cervical stenosis or amucorrhoea. Again this study was limited by size and incomplete
response rates. Of the 653 women, the majority reported that they had not stopped
contraception since their treatment - 452. Only 57 women reported trying to become pregnant,
of whom 11 succeeded, but 144 women did not answer this question on intention to become
pregnant. It is difficult to draw conclusions from this incomplete data and small numbers
As the cervix is necessary for sperm transit and subsequent fertility, it is likely that
factors, which affect the cervix, would also affect fertility. Therefore, women who attend
colposcopy for abnormal cervical cytology may be already at increased risk of fertility
problems which treatments such as surgery may accentuate.
In relation to cervical surgery, three potential mechanisms of damage have been proposed:
1. Cervical stenosis - needs to be complete to prevent sperm entry.
2. Secondary infection leading to ascending infection and tubal damage.
3. Changes in physical characteristics of cervical mucus.
However it must be noted that not all surgery on the cervix is the same. Specimens from
LLETZ and cone treatments vary in size considerably and as would be intuitively suspected
but also has been confirmed by studies, the thickness and volume of the specimens can
predict the relative risk of pregnancy related morbidity. No study has looked at whether
this size effect also relates to fertility.
Some studies suggest that sub-fertile women who attend for IVF are more likely to have
abnormal cervical cytology. As this is HPV related, they may also be more likely to have had
other sexually transmitted infections. These may have caused tubal damage, thus leading to
infertility problems.
The psychological impact of receiving abnormal smear results and having to attend colposcopy
has also been investigated. Recent studies now show that women are concerned and have
anxiety about the potential effect that such results and treatments will have on patients'
long term fertility. To be able to adequately reassure women that there will be no negative
consequences to their reproductive health it is vital that the investigators research the
fertility effects as well as the obstetric effects that possible treatments may have.
The investigators would like to investigate the relationship between cervical surgery and
infertility in a large group of women who have attended the colposcopy clinic in the
National Maternity Hospital, Holles Street between the years 2001 and 2007.
;
Observational Model: Cohort, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A |